Descamps Elodie, Petrault-Laprais Maud, Maurois Pierre, Pages Nicole, Bac Pierre, Bordet Régis, Vamecq Joseph
EA 1046, Pharmacology, Faculty of Medicine, Research Branch, IMPRT, University of Lille North of France, Place de Verdun, 59045 Lille Cedex, France.
Neurosci Res. 2009 Jun;64(2):137-42. doi: 10.1016/j.neures.2009.02.005. Epub 2009 Feb 20.
Induction of protein disulfide isomerase (PDI) is validated as a main mechanism by which 4-hydroxybenzyl alcohol (4-HBA), an active principle of Gastrodia elata Blume, reduces cerebral infarct volumes in a murine model of focal brain ischemia/reperfusion. In contrast to its position isomers, i.e. 3-hydroxybenzyl alcohol (3-HBA) and 2-hydroxybenzyl alcohol (2-HBA), and to aliphatic diols (1,4-butanediol and 1,5-pentanediol), 4-HBA administered intravenously at 25 mg/kg protected mice, significantly reducing total, cortical and sub-cortical infarct volumes by 42, 28 and 55%, respectively. All compounds, 4-HBA included, were devoid of antioedematous properties. Only the stroke protective 4-HBA, but neither 3-HBA nor 2-HBA, was capable of significantly inducing PDI in intact mouse brains. Stroke protection was fully prevented by bacitracin (500 mg/kg), a known inhibitor of PDI, which, without affecting basal brain PDI levels, altered the ability of 4-HBA to induce significantly PDI in intact brains. Taken as a whole, our data indicate that stroke protection induced by 4-HBA involves PDI as a key player, making this protein a valuable target to control brain injury disorders. The fact that 4-HBA, at doses up to 200mg/kg, was devoid of neurotoxicity in the rotarod test is also a decisive element to promote the neuroprotective use of this plant compound.
蛋白质二硫键异构酶(PDI)的诱导被确认为天麻活性成分4-羟基苄醇(4-HBA)在小鼠局灶性脑缺血/再灌注模型中减少脑梗死体积的主要机制。与它的位置异构体,即3-羟基苄醇(3-HBA)和2-羟基苄醇(2-HBA)以及脂肪族二醇(1,4-丁二醇和1,5-戊二醇)不同,以25mg/kg静脉注射4-HBA可保护小鼠,分别使总的、皮质和皮质下梗死体积显著减少42%、28%和55%。所有化合物,包括4-HBA,均无抗水肿特性。只有具有脑卒保护作用的4-HBA,而不是3-HBA或2-HBA,能够在完整的小鼠脑中显著诱导PDI。杆菌肽(500mg/kg)是一种已知的PDI抑制剂,可完全阻止脑卒中保护作用,它在不影响基础脑PDI水平的情况下,改变了4-HBA在完整脑中显著诱导PDI的能力。总体而言,我们的数据表明4-HBA诱导的脑卒中保护作用涉及PDI作为关键因素,使这种蛋白质成为控制脑损伤疾病的有价值靶点。4-HBA在高达200mg/kg的剂量下在转棒试验中无神经毒性这一事实也是促进这种植物化合物神经保护用途的决定性因素。